Notice of Special Interest (NOSI): Discovery and Development of Oral Small-molecule Direct-acting Antivirals Targeting Viruses of Pandemic Potential
National Institutes of Health
Description
This grant opportunity focuses on discovering and developing oral antiviral drugs targeting viruses with pandemic potential. The aim is to create a strong selection of drug candidates to be ready for future outbreaks and pandemics.
This NOSI aims to support the discovery and development of small molecule compounds with activity against viral targets that can be administered orally to treat infections caused by viruses of pandemic potential. The goal is to build a robust pipeline of candidate antiviral drugs for future outb…
Source
Grant ID
NOT-AI-24-053
Agency
National Institutes of Health
Subcategory/Subagency
National Institute of Allergy and Infectious Diseases
Key Dates
Opportunity Released
June 27, 2024
Eligibility
The following categories of applicants are invited to apply:
- Small Businesses
Similar opportunities
- Notice of Funding Opportunity for Next-Generation HIV Treatments and Preventive Strategies
National Institutes of Health
- Investigation of HIV-1 Envelope (Env) Cell Surface Expression and Development of Novel Approaches for Immunotherapies and Vaccines
National Institutes of Health
- Innovative Basic and Translational Pilot Research Projects in HIV/AIDS
National Institutes of Health
- Notice of Special Interest (NOSI): Using Targeted Degradation of Protein and non-Protein Targets for the Development of Novel Anti-Infectives
National Institutes of Health
- Notice of Special Interest (NOSI): Innovative Technologies to develop novel tools to prevent and treat HIV in underserved populations
National Institutes of Health